≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Psoas tendinitis

DOID EFO Endpoint Browser PheWeb

M13_PSOASTEND

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — M76.1
  • Cause of death: ICD-10 — M76.1

2 out of 7 registries used, show all original rules.

157

4. Check minimum number of events

None

157

5. Include endpoints

None

157

6. Filter based on genotype QC (FinnGen only)

157

Control definitions (FinnGen only)

Control exclude
M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
M76
Name in latin
Tendinitis musculi psoae

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 827 506 319
Only index persons 808 498 310
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.02 0.02 0.01
Median age at first event (years)
Whole population 48.04 49.29 46.15
Only index persons 47.94 49.19 45.94

-FinnGen-

Key figures

All Female Male
Number of individuals 157 109 48
Unadjusted period prevalence (%) 0.03 0.04 0.02
Median age at first event (years) 55.06 54.40 56.55

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
136
Matched controls
1359
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M76.1
ICD-10 Finland
Psoas tendinitis
+∞
196.4
136
*
NF1AA
NOMESCO Finland
Hip X-ray examination
15.5
22.6
38
33
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
30.2
20.5
27
11
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
81.9
19.3
21
*
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
36.0
19.1
24
8
M16.1
ICD-10 Finland
Other primary coxarthrosis
10.0
19.0
40
54
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
39.1
18.7
23
7
M76.0
ICD-10 Finland
Gluteal tendinitis
205.5
18.0
18
*
NFF25
NOMESCO Finland
Cleaning of hip joint, arthroscopic
179.7
15.8
16
*
L13
ICPC
Hip symptom/complaint
6.4
15.3
44
94
M48.0
ICD-10 Finland
Spinal stenosis
64.1
15.2
17
*
M01AH05
ATC
etoricoxib; oral
4.2
13.1
101
554
NE1AA
NOMESCO Finland
Pelvis X-ray examination
15.4
12.4
20
15
N02AX02
ATC
tramadol; systemic, rectal
3.9
12.3
71
300
M54.9
ICD-10 Finland
Dorsalgia, unspecified
10.8
12.1
23
25
N03AX16
ATC
pregabalin; oral
4.9
12.0
43
116
M79.6
ICD-10 Finland
Pain in limb
3.8
11.8
68
283
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
9.5
11.7
24
30
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
27.8
11.4
15
6
A02BC02
ATC
pantoprazole; systemic
3.8
11.3
104
623
NFG00
NOMESCO Finland
Arthroplasty of hip joint
+∞
10.5
10
*
NJ3NA
NOMESCO Finland
Measurement of difference in extremity lengty with X-ray
28.4
10.0
13
5
M54.5
ICD-10 Finland
Low back pain
3.8
9.8
48
171
A02BC05
ATC
esomeprazole; systemic
3.3
9.7
70
334
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
19.3
9.6
14
8
Q65.88
ICD-10 Finland
Other congenital deformities of hip
+∞
9.5
9
*
N06AX21
ATC
duloxetine; oral
5.8
9.3
27
56
M75.1
ICD-10 Finland
Rotator cuff syndrome
3.8
9.2
44
152
M54.4
ICD-10 Finland
Lumbago with sciatica
6.1
9.2
25
48
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.2
9.1
64
297
N03AX12
ATC
gabapentin; oral
5.5
8.7
26
56
NFL30
NOMESCO Finland
Transposition of muscle of hip or thigh
29.6
8.6
11
*
M25.5
ICD-10 Finland
Pain in joint
3.2
8.6
57
250
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
+∞
8.4
8
*
NFE15
NOMESCO Finland
Plastic repair of capsule or ligament of hip joint
+∞
8.4
8
*
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
6.7
8.4
21
36
M01AB55
ATC
diclofenac, combinations; oral
10.4
8.0
15
16
L89
ICPC
Osteoarthrosis of hip
16.3
7.9
12
8
M03BX02
ATC
tizanidine; oral
2.9
7.8
97
624
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
26.7
7.7
10
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.1
7.6
48
201
M70.6
ICD-10 Finland
Trochanteric bursitis
4.4
7.4
27
72
M01AE02
ATC
naproxen; oral, rectal
2.7
7.3
89
557
M16.3
ICD-10 Finland
Other dysplastic coxarthrosis
31.8
7.2
9
*
NF1DA
NOMESCO Finland
X-ray of hips
17.8
6.9
10
6
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
5.8
6.6
18
35
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.6
6.5
67
372
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
73.1
6.5
7
*
N02BE01
ATC
paracetamol; systemic, rectal
3.6
6.5
122
959
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
4.7
6.4
21
51
N02AJ06
ATC
codeine and paracetamol; systemic
2.6
6.3
56
284
J01DB01
ATC
cefalexin; oral
3.2
6.3
118
910
UDQ12
NOMESCO Finland
Flexible laryngoscopy
7.3
6.2
14
21
M16
ICD-10 Finland
Coxarthrosis [arthrosis of hip]
7.3
6.2
14
21
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.9
6.0
40
171

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
76
356
3.20
11.60
2.4
2.2
u/l
52.1
55.5
0.57
71
331
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
83
435
2.93
10.00
3.4
3.0
ng/l
19.1
38.5
1.14
46
271
(3022096) Basophils/100 leukocytes in Blood
95
541
2.91
9.71
6.0
5.0
%
0.6
0.7
0.91
87
506
(3019069) Monocytes/100 leukocytes in Blood
98
568
2.93
9.68
6.2
5.3
%
7.9
8.6
1.36
91
538
(3002030) Lymphocytes/100 leukocytes in Blood
100
586
2.95
9.67
6.2
5.1
%
29.0
28.5
0.22
91
554
(3044640) Blood type and Crossmatch panel - Blood
74
375
2.84
9.35
2.6
2.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
60
272
2.95
9.32
2.7
2.0
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
96
562
2.82
9.11
6.1
5.0
%
2.7
2.7
0.11
89
529
(3018010) Neutrophils/100 leukocytes in Blood
98
580
2.84
9.10
5.9
5.1
%
57.5
56.9
0.20
91
551
(3013512) EKG study
68
336
2.81
8.93
5.0
3.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
137
989
4.02
8.70
4.8
3.8
pmol/l
14.7
14.6
0.22
126
900
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
96
575
2.72
8.50
3.7
3.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
40
151
3.21
8.46
1.2
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
72
377
2.68
8.32
6.2
5.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
100
618
2.70
8.21
6.2
5.6
e9/l
0.2
0.2
0.14
86
555
(3019198) Lymphocytes [#/volume] in Blood
99
613
2.66
8.03
6.2
5.1
e9/l
1.8
2.2
0.83
86
549
(3006315) Basophils [#/volume] in Blood
97
595
2.65
8.02
6.0
5.1
e9/l
0.0
0.0
0.77
82
522
(3001604) Monocytes [#/volume] in Blood
97
595
2.65
8.02
5.9
5.1
e9/l
0.5
0.6
0.89
82
521
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
130
950
3.14
7.21
7.1
6.9
u/l
69.2
77.0
3.27
125
889
(3037467) Urinalysis macro (dipstick) panel - Urine
118
825
2.73
7.04
5.7
3.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
47
216
2.68
6.85
1.6
1.2
iu/ml
16.1
32.2
1.24
19
76
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
45
205
2.68
6.65
1.4
1.3
u/ml
18.0
6.2
0.32
21
79
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
89
561
2.35
6.43
7.8
6.6
mmol/l
1.2
1.2
0.74
78
484
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
37
157
2.77
6.24
4.4
4.0
%
34.0
33.3
0.11
26
100
(3013650) Neutrophils [#/volume] in Blood by Automated count
104
709
2.38
6.16
6.7
9.7
e9/l
3.8
4.0
0.47
85
628
(3032080) INR in Blood by Coagulation assay
75
457
2.23
5.67
7.1
5.6
inr
1.1
1.2
0.13
17
149
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
54
292
2.29
5.40
2.6
3.0
ng/l
897.0
867.5
0.03
46
251
(3026493) Urate [Moles/volume] in Serum or Plasma
52
277
2.31
5.38
3.1
2.7
umol/l
339.8
5112.4
1.32
46
250
(3009261) Glucose [Presence] in Urine by Test strip
88
581
2.17
5.34
4.3
3.3
estimate
0.0
0.0
0.50
12
116
(3035350) Ketones [Presence] in Urine by Test strip
87
574
2.16
5.27
4.3
3.3
estimate
0.0
0.0
0.00
12
117
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
149
1292
4.01
5.06
18.2
11.0
mg/l
19.5
22.4
0.51
133
976
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
72
447
2.13
5.05
1.8
1.8
pmol/l
109.8
99.4
1.02
35
227
(3024928) Oxygen saturation in Venous blood
10
20
5.27
4.84
2.9
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
145
1212
3.57
4.79
6.1
4.5
mu/l
1.7
2.9
0.63
134
1104
(3021601) Nitrite [Presence] in Urine by Test strip
86
580
2.07
4.75
6.9
4.6
estimate
0.0
0.0
0.50
11
121
(3013139) Helicobacter pylori Ag [Presence] in Stool
21
76
3.04
4.66
1.4
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
22
86
2.81
4.27
3.6
3.8
%
0.0
0.3
—
6
22
(3037522) Nuclear Ab [Titer] in Serum
34
168
2.31
4.09
1.5
1.4
titre
325.0
378.9
—
8
36
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
75
503
1.94
4.01
6.5
5.2
mmol/l
1.2
1.2
1.26
64
457
(3019225) pH of Specimen
24
102
2.60
3.98
5.6
5.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
20
78
2.79
3.90
3.1
1.9
e9/l
3.3
3.9
0.76
12
64
(3013826) Glucose [Moles/volume] in Serum or Plasma
95
694
1.93
3.89
3.9
4.0
mmol/l
6.2
6.7
1.71
88
631
(3025159) Blasts/100 leukocytes in Blood
21
85
2.70
3.82
3.7
3.7
%
0.0
0.1
—
5
18
(3008898) HLA-B27 [Presence]
16
56
3.07
3.75
1.1
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
72
489
1.87
3.61
2.1
2.2
nmol/l
81.6
74.8
1.28
65
437
(3002179) Metamyelocytes/100 leukocytes in Blood
20
82
2.65
3.55
3.2
3.9
%
0.2
0.4
—
5
16
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
145
1261
2.96
3.48
5.1
4.1
mmol/l
5.8
5.9
0.79
132
1150
(3017181) Myelocytes/100 leukocytes in Blood
22
96
2.50
3.45
3.6
3.7
%
0.3
0.9
—
6
28
(3025941) Bacteria identified in Stool by Culture
18
71
2.73
3.43
1.1
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
113
894
1.94
3.43
3.1
2.7
u/l
36.7
43.5
0.85
106
846
(40760892) CBC W Ordered Manual Differential panel - Blood
47
283
1.94
3.35
4.5
4.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
44
259
1.97
3.35
2.5
1.9
mg/l
2.4
3.2
2.28
37
222
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
112
888
1.91
3.32
2.9
3.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
7
8.85
3.29
1.0
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
68
464
1.82
3.28
4.5
3.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
16
5.21
3.09
1.8
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
31
167
2.07
2.99
2.6
1.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
10
30
3.49
2.96
1.1
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
23
111
2.26
2.90
1.7
1.9
nmol/l
331.3
393.3
0.81
23
103
(3041096) Erythrocytes [Presence] in Urine by Automated
53
346
1.80
2.90
4.5
3.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
72
514
1.74
2.90
1.9
2.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
6
8.55
2.77
1.0
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
152
1405
3.57
2.75
11.9
9.0
u/l
23.8
25.7
1.21
147
1355
(3048929) Epstein Barr virus Ab [Presence] in Serum
11
37
3.12
2.75
1.3
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
28
150
2.05
2.74
1.6
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
51
336
1.77
2.68
3.6
2.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
31
174
1.97
2.67
1.6
1.6
nmol/l
1133.5
1139.1
0.01
21
127
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
142
1258
2.35
2.63
16.1
10.2
ml/min/173m2
81.6
85.6
1.34
118
1011
(3012544) pH of Venous blood
20
95
2.27
2.62
4.2
2.2
—
—
—
0
0
(4010399)
18
82
2.35
2.59
1.1
1.3
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
17
76
2.39
2.55
2.7
2.3
e6/l
0.0
0.1
1.45
17
70
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
9
26
3.61
2.52
1.4
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
16
4.53
2.50
1.3
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
31
179
1.91
2.46
3.5
2.5
e6/l
4.2
3.9
0.05
18
97
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
12
5.15
2.42
1.8
2.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
40
252
1.79
2.42
1.6
1.5
mg/l
0.7
1.0
0.90
31
193
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
5
8
6.41
2.39
1.0
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
140
1245
2.15
2.37
4.2
3.7
mmol/l
1.3
1.3
0.14
128
1148
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
44
288
1.73
2.33
1.4
1.2
u/ml
0.8
0.8
0.00
13
77
(3023368) Bacteria identified in Blood by Culture
41
263
1.76
2.33
5.6
3.7
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
56
392
1.67
2.32
4.4
2.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
18
4.02
2.28
1.4
1.4
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
7
18
4.02
2.28
1.9
1.4
—
—
—
0
0
(3026782) Osmolality of Urine
34
208
1.81
2.26
4.1
2.6
mosm/kgh2o
541.7
568.4
0.42
28
182
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
9
5.69
2.23
1.0
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
145
1315
2.34
2.19
5.2
4.5
mmol/l
2.9
2.8
0.61
132
1219
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
42
278
1.70
2.12
1.9
1.5
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
8
25
3.31
2.12
2.3
1.5
nmol/l
54.8
30.3
—
8
25
(3044290) Cell count panel - Cerebral spinal fluid
8
25
3.31
2.12
1.0
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
10
5.12
2.08
4.8
2.2
e9/l
4.5
3.6
—
5
10
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
143
1295
2.17
2.08
4.5
4.1
mmol/l
4.9
4.7
0.90
131
1206
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
15
4.11
2.06
1.0
1.1
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
8
26
3.19
2.04
4.6
2.3
mmol/l
1.1
1.1
—
8
26
(3022145) Colonoscopy Study observation
26
151
1.87
2.03
1.2
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
21
114
1.97
1.99
2.9
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
30
184
1.78
1.97
3.2
2.3
e6/l
1.3
1.2
0.16
17
99
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
11
4.65
1.95
5.8
2.5
%
67.0
54.4
—
5
11
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
142
1290
2.05
1.93
4.8
4.0
mmol/l
1.5
1.5
0.05
130
1192
(3019230) Fractional oxyhemoglobin in Venous blood
6
17
3.63
1.85
3.8
1.6
%
70.7
59.4
—
6
17
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
132
1177
1.76
1.84
6.7
5.3
mmol/mol
38.8
39.5
0.41
122
1091
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
12
4.26
1.83
1.0
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
12
4.26
1.83
1.2
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
12
4.26
1.83
1.6
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
12
4.26
1.83
1.6
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
27
164
1.78
1.83
1.7
2.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
11
47
2.44
1.82
1.8
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
24
142
1.81
1.77
1.7
1.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
36
2.59
1.77
1.9
1.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
13
3.93
1.73
1.0
1.0
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
7
25
2.88
1.67
5.0
2.3
mmol/l
5.7
6.9
—
7
25
(3045424) Erythrocytes [Presence] in Urine
6
20
3.08
1.59
2.0
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
37
255
1.59
1.58
3.8
3.3
kg/l
1.0
1.0
—
6
28
(3003327) Ova and parasites identified in Stool by Light microscopy
10
44
2.36
1.56
2.4
1.5
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
15
3.41
1.53
1.0
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
46
336
1.52
1.53
4.2
2.7
e6/l
109.5
72.3
0.21
36
250
(3018095) Leukocytes [#/volume] in Urine
53
400
1.49
1.50
5.2
3.2
e6/l
93.2
108.0
0.08
38
268
(3011397) Hemoglobin [Presence] in Urine by Test strip
36
250
1.57
1.49
3.3
3.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
62
486
1.46
1.45
4.6
3.9
g/l
36.4
36.3
0.06
55
457
(3023410) Appearance of Cerebral spinal fluid
5
16
3.19
1.45
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
22
2.79
1.45
1.3
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
22
2.79
1.45
1.3
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
42
307
1.50
1.38
3.5
3.4
estimate
0.0
0.0
0.68
12
120
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
17
3.00
1.37
2.4
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
17
3.00
1.37
2.4
1.6
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
5
17
3.00
1.37
1.4
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
17
3.00
1.37
2.4
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
17
3.00
1.37
2.4
1.6
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
11
54
2.12
1.36
3.1
2.1
%
0.9
1.3
0.94
11
54
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
18
2.83
1.29
2.4
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
18
2.83
1.29
2.4
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
36
2.29
1.26
8.7
4.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
15
86
1.82
1.24
1.3
1.2
u/ml
72.1
147.5
1.15
15
78
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
32
226
1.52
1.23
1.8
1.7
pmol/l
429.4
439.1
0.08
27
191
(40760888) Immunoglobulin light chains.free panel - Serum
5
19
2.68
1.22
2.8
3.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
26
2.36
1.20
2.2
1.6
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
10
50
2.07
1.19
6.2
2.9
%
39.8
48.6
—
10
50
(3017143) Hepatitis C virus Ab [Presence] in Serum
24
160
1.59
1.18
2.1
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
20
2.55
1.16
1.8
1.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
15
89
1.76
1.12
1.3
1.2
iu/ml
227.5
175.6
—
6
38
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
19
121
1.65
1.12
3.7
4.6
ug/l
2.1
42.6
0.57
14
95
(3048689) Calprotectin [Mass/mass] in Stool
24
163
1.56
1.10
1.7
2.2
ug/g
67.4
93.5
0.56
16
125
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
21
2.42
1.10
1.4
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
32
2.24
1.09
1.4
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
22
147
1.58
1.08
1.8
1.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
13
75
1.80
1.06
1.4
2.5
u/ml
17.2
75.4
1.06
13
70
(3030467) Casts [#/volume] in Urine by Automated count
39
296
1.42
1.05
4.1
2.6
e6/l
0.3
0.5
0.60
28
212
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
22
2.31
1.04
1.6
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
9
48
1.93
1.02
1.4
1.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
35
262
1.43
1.02
1.5
1.4
g/l
2.2
2.2
0.00
26
166
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
23
2.21
0.98
1.0
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
9
50
1.85
0.98
1.2
2.0
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
9
50
1.85
0.98
4.6
7.0
mmol/l
24.0
25.2
—
9
50
(3003694) ABO and Rh group [Type] in Blood
49
394
1.35
0.94
1.2
1.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
9
52
1.77
0.94
1.4
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
10
56
1.84
0.90
8.1
3.7
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
6
30
2.04
0.88
1.2
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
6
30
2.04
0.88
1.2
1.4
u/l
9.2
8.7
—
6
25
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
10
57
1.81
0.86
3.3
3.8
kpa
5.3
5.6
—
10
52
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
20
139
1.50
0.84
1.5
1.8
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
33
1.85
0.80
1.3
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
20
141
1.48
0.79
2.6
6.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
131
1230
1.39
0.78
18.1
12.0
%
40.1
39.9
0.10
94
956
(3018418) pH of Serum or Plasma
42
340
1.32
0.76
5.9
3.5
ph
7.4
7.4
—
9
52
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
5
24
2.12
0.75
1.8
1.4
—
12.5
—
0
5
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
9
55
1.67
0.75
2.4
2.5
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
7
38
1.88
0.74
4.0
3.9
mmol/l
25.4
26.2
—
7
38
(3018677) aPTT in Platelet poor plasma by Coagulation assay
22
161
1.43
0.73
1.8
1.6
s
30.5
29.5
0.33
22
156
(3045414) Leukocytes [Presence] in Urine
7
41
1.74
0.71
1.9
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
33
261
1.33
0.70
2.0
1.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
30
234
1.35
0.70
3.7
3.6
%
25.3
21.0
0.74
13
108
(3022313) Gas panel - Capillary blood
7
43
1.66
0.67
4.0
3.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
12
78
1.58
0.67
5.2
6.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
10
63
1.63
0.63
2.1
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
49
1.67
0.63
1.6
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
15
105
1.47
0.62
1.0
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
26
202
1.34
0.62
4.4
3.0
ng/l
18.6
430.0
0.72
16
143
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
12
80
1.54
0.62
2.9
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.61
0.0
1.7
—
—
—
0
0
(4268621)
0
21
0.00
0.60
0.0
2.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
22
0.00
0.60
0.0
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
66
582
1.23
0.59
8.5
7.8
e9/l
0.0
0.0
0.71
52
476
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
23
0.00
0.59
0.0
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
12
82
1.50
0.56
1.3
1.8
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
106
1128
0.81
0.53
23.8
13.9
%
13.8
13.6
0.18
106
1108
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
9
63
1.45
0.53
1.2
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
13
92
1.45
0.52
1.0
3.3
ml/min/173m2
90.2
66.7
—
6
35
(36304419) Bacteria [Presence] in Urine
35
293
1.25
0.50
4.0
2.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
18
137
1.35
0.50
1.4
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
11
76
1.48
0.49
2.3
3.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
21
165
1.31
0.48
3.4
2.8
ug/l
1.0
0.7
0.30
11
107
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
7
48
1.48
0.47
3.6
8.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
11
78
1.44
0.44
1.0
1.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
13
96
1.39
0.43
1.9
2.5
g/l
11.0
10.3
0.31
13
87
(1761868) Lipid panel - Serum or Plasma
58
520
1.18
0.42
3.3
2.6
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
5.5
—
19.8
—
0
6
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
34
1.49
0.40
2.0
2.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
35
1.44
0.39
1.4
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
35
1.44
0.39
1.4
1.1
—
—
—
0
0
(4306422)
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
19
0.00
0.39
0.0
1.9
—
—
—
0
0
(3000492) Spirometry study
15
116
1.32
0.38
1.3
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
5
36
1.40
0.38
1.4
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
5
78
0.63
0.36
3.6
2.3
ng/l
172.2
82.7
—
5
71
(3049717) Cytology report of Urine Cyto stain
6
43
1.41
0.35
2.8
3.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
45
401
1.17
0.35
3.1
3.2
mmol/l
2.3
2.4
0.16
39
358
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
26
221
1.21
0.33
2.0
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
29
250
1.20
0.32
1.4
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
7
99
0.69
0.32
5.3
3.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
7
54
1.31
0.31
2.7
2.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
21
176
1.22
0.31
1.8
1.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
12
96
1.27
0.25
1.8
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
20
171
1.19
0.25
1.1
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
37
1.36
0.24
1.2
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
10
79
1.28
0.23
1.0
2.0
g/l
1.3
1.5
—
10
73
(21494755) Public health laboratory ask at order entry panel
14
166
0.83
0.21
1.0
1.3
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
0
11
0.00
0.21
0.0
2.9
—
49.2
—
0
5
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.7
—
14.0
—
0
10
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
27.2
—
1872.8
—
0
10
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
7.9
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
17.5
—
974.4
—
0
10
(4024509)
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
0
13
0.00
0.21
0.0
1.8
—
5.4
—
0
7
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
38
349
1.12
0.19
4.1
4.2
mg/mmol
1.6
9.0
2.58
25
228
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
62
1.13
0.17
1.4
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
5
65
0.76
0.17
2.6
4.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
12
141
0.84
0.17
1.5
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
13
114
1.15
0.12
2.0
1.7
—
—
—
0
0
(3044889) 12 lead EKG panel
87
893
0.94
0.10
3.2
3.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
44
1.14
0.10
3.0
2.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
10
114
0.87
0.10
4.3
2.9
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
6
57
1.05
0.08
4.0
8.9
%
94.8
94.4
—
6
57
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
13
117
1.12
0.08
2.1
1.8
—
—
—
0
0
(1002224) Polysomnography panel
7
64
1.10
0.08
1.1
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
7
66
1.06
0.08
1.6
2.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
11
98
1.13
0.08
2.3
1.9
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
12
108
1.12
0.07
2.3
1.9
g/l
0.2
0.2
0.46
12
100
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
78
1.03
0.07
2.1
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
34
325
1.06
0.07
4.2
7.0
—
—
—
0
0
(4035726)
11
109
1.01
0.00
1.1
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
32
325
0.98
0.00
3.5
3.4
mg/l
1877.9
273.2
0.39
21
217
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
10.7
—
0
7
(3014271) Vancomycin [Susceptibility]
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
98
0.91
0.00
1.4
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
7
0.00
0.00
0.0
1.0
—
134.4
—
0
7
(3029075) Extractable nuclear Ab panel - Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
8
0.00
0.00
0.0
2.4
—
112.6
—
0
8
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
6
0.00
0.00
0.0
1.7
—
9.8
—
0
6
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
8.9
—
0
9
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
30.1
—
0
6
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint M13_PSOASTEND and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have M13_PSOASTEND.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: M13_PSOASTEND – Psoas tendinitis

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data